Pictet-Biotech I dy GBP
SpecialistPricing frequency
Daily
Dealing cut off time
11:00
Type
SICAV
Yield
–
NAV
£1,356.34
Income frequency
Annually
Ongoing charge
1.1%
Latest actual NAV date
13-11-2026
ISIN
LU0448836352
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Genmab AS ADR | 5.24 |
| Vertex Pharmaceuticals Inc | 4.83 |
| United Therapeutics Corp | 4.80 |
| argenx SE ADR | 4.58 |
| Roivant Sciences Ltd Ordinary Shares | 4.18 |
| Insmed Inc | 3.98 |
| Amgen Inc | 3.93 |
| BridgeBio Pharma Inc | 3.87 |
| Biogen Inc | 3.68 |
| Revolution Medicines Inc Ordinary Shares | 3.14 |
Investment objective
The fund seeks to increase the value of your investment while seeking to achieve a positive social impact.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.